Delivery Order SPE2DB25D7068-SPE2DB26FTVBC
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,119.97 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (100-count) on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,119.60 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets in unit dose packaging containing 100 tablets. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,078.62 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) with a completion date of November 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $8,787 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award from the agency's Medical Supply Chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- The Defense Logistics Agency awarded a delivery order valued at $21,296.45 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with a completion date of September 30, 2025. This competitive award, issued on September 29, 2025, involves firm fixed pricing with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $5,680.22 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,354.67 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500-count supply) on July 14, 2025, with an ultimate completion date of July 15, 2025. This contract was awarded on a non-competitive, firm fixed-price basis under a delivery order structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this award represents a routine fulfillment...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB26FTVBCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,500.09 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (300-count units). This competitive, non-set-aside contract employs firm fixed pricing and was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle supports military healthcare systems worldwide by enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The current order represents a routine fulfillment of the company's capacity to provide generic pharmaceutical commodities to federal healthcare customers, including the Defense Health Agency and U.S. Coast Guard, as part of the broader Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/3/25 |